CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study
Clinical trial NCT00013806 · UNKNOWN
Trial details
- NCT number
- NCT00013806
- Sponsor
- National Center for Research Resources (NCRR)
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.